Skip to main content

Table 5 HPV Types detected in patient samples by sequencing using consensus primers GP5+/GP6+

From: Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients

Case # HPV type
1 7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97
2 7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97
3 7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97
4 7,13,16,18,39,40,43,59,61,68,70,77,91,97
5 7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97
6 7,13,16,18,39,40,43,59,68,70,77,91,97
8 7,13,16,18,29,39,40,43,45,59,61,68,70,77,85,91,97
9 7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97
11 7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97
12 16,18,39,40,43,45,59,61,68,70,77,85,91,97
13 7,13,16,18,39,40,43,45,59,61,68,70,74,85,91,97
14 16,18,29,39,40,43,45,59,68,70,85,91,97
15 7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97
16 7,13,16,18,39,40,43,45,59,61,68,70,74,77,85,91,97
17 7,13,16,18,29,39,40,43,45,59,61,68,70,77,85,91,97
18 7,16,18,39,40,61,70,77,85,91,97
19 16,18,39,40,43,45,61,70,77,85,91,97
21 7,13,16,40,45,70,77,85
22 7,13,16,39,43,45,70,85
23 7,13,43,45,70,77,85
24 7,43,45,85
25 13,16,18,39,40,43,45,59,61,68,70,77,85,91,97
26 13,16,18,39,40,43,45,59,61,68,70,77,85,91,97
27 1,3,7,11,13,16,18,39,40,43,45,59,61,68,70,77,85,89,91,97
28 29,43,45,59,85
29 45,59,68,70,85
30 1,3,7,11,13,16,18,39,40,43,45,59,61,68,70,77,85,89,91,97
31 16,18,43,45,59,68,70
32 16,18,43,45,59,61,68,70
33 1,13,16,18,39,40,43,44,45,55,59,61,68
34 7,13,16,18,39,43,45,59,61,68,97
35 7,16,18,39,40,43,45,59,61,68,74
36 16,18,39,45,59,61,68,77,97
37 7,13,16,18,39,43,45,59,61,68,77,97
38 7,13,16,18,39,40,43,44,45,55,59,68,74,77,97
39 7,18,39,40,43,59,61,68,74,77,91,97
  1. HPV types identified in patient samples by sequencing with the consensus primer GP5+/GP6+. The most commonly identified HPV type in both OSSN and pterygium tissues included the high risk HPV-18, 16, 45, 39, 59, and 68.